No Data
No Data
Luxin Venture Capital Group (600783.SH): The company plans to issue Bonds products.
On December 13, Gelonghui reported that Luxin Venture Capital Group (600783.SH) announced that to meet the needs of the company's Operation and ensure the funding demands for its external investment Business, the company will hold the 30th meeting of the 11th Board of Directors on December 13, 2024. The meeting unanimously reviewed and approved the proposal regarding the company's plan to issue Bonds products, with a total registration and issuance scale of various domestic Bonds products not exceeding 1 billion yuan. The funds raised from the Bonds products will be used to replenish working capital and for Private Equity investments. The management team is authorized to determine the application and issuance according to the company's funding needs and market conditions.
Luxin Venture Capital Group (600783.SH): A subsidiary plans to transfer the rights to the share profits of Longli Biotechnology.
Gelonghui, December 13 - Luxin Venture Capital Group (600783.SH) announced that, in order to further reduce the non-performing Assets ratio, its wholly-owned subsidiary ShanDong Gaoxin Investment plans to transfer the income rights corresponding to its 9.79% stake in Longli Biological to ShanDong Jinzi for a price of 4.3962 million yuan.
The State-owned Assets Supervision and Administration Commission and the National Development and Reform Commission jointly issued significant venture capital policies, and the equity market is expected to enter a period of development and prosperity.
① The State-owned Assets Supervision and Administration Commission (SASAC) and the National Development and Reform Commission jointly issued policy measures to promote the high-quality development of venture capital funds by central enterprises, supporting these enterprises to initiate and establish venture capital funds, focusing on early-stage, small-scale, long-term investments, and hard technology. ② Citic sec research reports indicate that in the context of the secondary market entering a valuation expansion cycle, with the increasing linkage effect between the primary and secondary markets, the equity market will also move towards a prosperous period of high-quality development.
Luxin Venture Capital Group (600783.SH): The company and its affiliated funds did not participate in the investment in Moore Thread.
Luxin Venture Capital Group (600783.SH) stated on the investor interaction platform that the company and its affiliated funds did not participate in the investment in Mole Thread Asia Vets Technology (Beijing) Co., Ltd.
Luxin Venture Capital Group's (SHSE:600783) Earnings Are Built On Soft Foundations
Luxin Venture Capital: Luxin Venture Capital 2024 Third Quarter Report
